Crossmark

Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

Crossref DOI link: https://doi.org/10.1186/s12933-024-02192-4

Published Online: 2024-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmad, Aftab

Sabbour, Hani https://orcid.org/0000-0001-6960-1056
License Information

Text and Data Mining valid from 2024-03-18

Version of Record valid from 2024-03-18
More Information

Article History

Received: 27 December 2023

Accepted: 6 March 2024

First Online: 18 March 2024

Change Date: 1 June 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s12933-024-02283-2

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Updates are available Correction dated 2024-06-01

Click to view Correction: https://doi.org/10.1186/s12933-024-02283-2